Lung Diseases, Obstructive: all 2,585 studies
Page 18 of 26. Open to participants first (194), then studies with results posted, then the rest; newest registration first within each.
- Continuous Versus Interval Walking Training in Patients With COPD - a Pilot StudyCompletedNCT02209207Not applicable
- BACE Trial Substudy 2 - FarmEc SubstudyCompletedNCT02205255Phase 3
- A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary DiseaseWithdrawnNCT02203474Phase 2
- Pursed-lips Breathing and Dynamic HyperinflationCompletedNCT02203058Not applicable
- Effects of Combined Cycle Training and Inspiratory Muscle Training in Patients With COPDCompletedNCT02200549Not applicable
- Effects of Nutritional Supplementation in Malnourished Patients in Stable COPDStatus unknownNCT02197871Phase 4
- Flutiform® Compared With Seretide® in the Treatment of COPDCompletedNCT02195375Phase 2/3
- Efficacy and Safety of Glycopyrrolate Bromide of COPD PatientsCompletedNCT02189577Phase 2
- Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in GreeceCompletedNCT02187926
- Effects of Inspiratory Muscle Training on Breathing Pattern in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02186340Not applicable
- Probiotic Use in Patients With Prior COPD ExacerbationWithdrawnNCT02185092Not applicable
- Acute Effect of Aclidinium on Hyperinflation and Ventilation Inhomogeneity in Severe COPD PatientsCompletedNCT02181023Phase 4
- Identifying REsponders and Exploring Mechanisms of ACTION of the Endobronchial Coil Treatment for EmphysemaCompletedNCT02179125Not applicable
- Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary DiseaseCompletedNCT02177344Phase 3
- Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary DiseaseCompletedNCT02177253Phase 3
- Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT02176200Phase 3
- Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary DiseaseTerminatedNCT02176187Phase 3
- Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02175342Phase 2
- Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed ConditionCompletedNCT02173795Phase 3
- Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172807Phase 3
- Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172794Phase 3
- A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat InhalerCompletedNCT02172560
- Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary RehabilitationTerminatedNCT02172508Phase 4
- Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172469Phase 3
- Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary DiseaseCompletedNCT02172443Phase 3
- Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172287Phase 3
- Quadricipital Electrical Stimulation in COPD Patients RehabilitationCompletedNCT02171377Not applicable
- Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract InfectionsStatus unknownNCT02171338Phase 4
- Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.CompletedNCT02165046Phase 1
- Is COPD a Risk Factor for Cardiovascular Disease?CompletedNCT02162095
- Safety, Tolerability and Preliminary Efficacy of Adipose Derive Stem Cells for Patients With COPDTerminatedNCT02161744Phase 1
- Physical Activity Versus Pulmonary Rehabilitation in COPDCompletedNCT02161393Not applicable
- Fat Metabolism in OSA and COPDCompletedNCT02157844
- Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric TrainingCompletedNCT02156245Not applicable
- Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and SleepCompletedNCT02150590Phase 4
- Dietary Nitrate in COPDCompletedNCT02148289Not applicable
- Evaluation of Depression In Chronic Obstructive Pulmonary DiseaseStatus unknownNCT02147912Not applicable
- Personalized Variable Versus Fixed Dose Glucocorticoid Therapy in AECOPDCompletedNCT02147015Not applicable
- Music Therapy in the Treatment of Chronic Obstructive Pulmonary DiseaseCompletedNCT02146235Not applicable
- Cognitive Status in Chronic Obstructive Pulmonary Disease's PatientsStatus unknownNCT02143700
- Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise PerformanceCompletedNCT02143609Phase 4
- Modifying Exercise for the COPD PatientCompletedNCT02143206
- A Comparison Study of Two Respiratory Physical Therapy Methods and Standard Medical Treatment for Treating COPD Patients During Acute ExacerbationStatus unknownNCT02140892Not applicable
- A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPDCompletedNCT02140346Phase 1
- Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an ExacerbationCompletedNCT02136875Phase 4
- Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce ReadmissionsCompletedNCT02135744Not applicable
- Azithromycin for Acute Exacerbations Requiring HospitalizationTerminatedNCT02135354Phase 3
- Single Ascending Dose Study of TRN-157 in Healthy SubjectsCompletedNCT02133339Phase 1
- Efficacy of Inhalation Technique Training.CompletedNCT02131454Not applicable
- Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02128529
- Exercise and Neutrophil Function in COPDCompletedNCT02124343Not applicable
- Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPDCompletedNCT02123199
- Vitamin D Supplementation in Patients With COPDCompletedNCT02122627Not applicable
- Home-monitoring and Adherence of Patients With COPD to Long-term RehabilitationCompletedNCT02122614Not applicable
- Phenotypes of COPD in Central and Eastern EuropeCompletedNCT02119494
- Validation of Medication Non-adherence Model (UK)CompletedNCT02115412
- Is it Necessary to Set External PEEP in AECOPD PatientsCompletedNCT02114567Not applicable
- Efficacy and Safety Study of Two Dose Levels of AZD2115 in Subjects With Moderate to Severe COPDCompletedNCT02109406Phase 2
- Effect of Oxygen Supplementation During Exercise in Chronic Obstructive Pulmonary Disease PatientsCompletedNCT02108925Not applicable
- The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD)WithdrawnNCT02107222Not applicable
- Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady StateCompletedNCT02103374Phase 4
- The Effect of NIV on QoL and Exercise Capacity in a COPD Exercise Rehabilitation ProgramTerminatedNCT02100709Not applicable
- A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02100332
- Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease PatientsStatus unknownNCT02093195Phase 2
- Endothelial Dysfunction and Chronic Obstructive Pulmonary DiseaseCompletedNCT02092675
- Physical Activity and Self-Efficacy After Pulmonary RehabilitationStatus unknownNCT02086383
- ECCO2R as an Adjunct to NIV in AECOPDCompletedNCT02086084Not applicable
- Early Telemedicine Training in Patients With COPDCompletedNCT02085187Not applicable
- Nitrate Supplementation in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02084758Not applicable
- Balance Training for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02080442
- Use of Respiratory Therapists (RTs) to Improve Outcomes and Quality of Life in Patients With COPDCompletedNCT02078622
- Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles ComparisonCompletedNCT02076269Phase 1
- Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal StudyCompletedNCT02076061
- Inspiratory Muscle Training During Pulmonary Rehabilitation in COPDCompletedNCT02074813Not applicable
- A Population-based Investigation of Asthma in the Telemark Region of NorwayActive, not recruitingNCT02073708
- Efficacy of Simvastatin for the Treatment of COPDCompletedNCT02070133Phase 3
- Post Marketing Surveillance of Roflumilast in KoreaCompletedNCT02068456
- Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPDCompletedNCT02067780Phase 3
- Evaluation of the Safety of the Medical Device Simeox®TerminatedNCT02061852Not applicable
- Novel Vascular Manifestations of Chronic Obstructive Pulmonary DiseaseCompletedNCT02060292
- Targeted Lung Denervation for Patients With Moderate to Severe COPDCompletedNCT02058459Not applicable
- Correction of Exercise-induced Desaturation by Acute Oxygen Supply and Exercise Responses in COPDCompletedNCT02055885
- Clinical Practice of AECOPD Management in ChinaCompletedNCT02051166
- The Effects of Physical Exercise Training in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02050945Not applicable
- Effects of Pulmonary Rehabilitation on Respiratory Sounds in Patients With COPDCompletedNCT02050711Not applicable
- Improving End-of-life Care by Continuing Medical Education and Electronic Decision Making Support for General PractitionersWithdrawnNCT02050256Not applicable
- Chronic Obstructive Pulmonary Disease Biomarker StudyStatus unknownNCT02050022
- Impact of Family-based Pulmonary Rehabilitation (PR) on Patients With Chronic Obstructive Pulmonary Disease (COPD) and Their Family MembersCompletedNCT02048306Not applicable
- Epidemiology and Diagnosis of Haemoptysis: a Multicenter StudyCompletedNCT02045394
- Mindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary DiseaseCompletedNCT02042976Not applicable
- Adipose Derived Cells for Chronic Obstructive Pulmonary DiseaseWithdrawnNCT02041000Not applicable
- A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment.CompletedNCT02040597Phase 1
- Exhaled Breathing Condensate (EBC) Features and Lung Function Decline in Chinese AdultsStatus unknownNCT02037828
- STRETCH OF RESPIRATORY MUSCLES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASECompletedNCT02036762Phase 2/3
- Abdominal Functional Electrical Stimulation to Reduce Hyperinflation in Chronic Obstructive Pulmonary Disease PatientsCompletedNCT02035228Not applicable
- Expanding Paramedicine in the CommunityCompletedNCT02034045Not applicable
- Thoracic Lymphatic Pump Techniques for Reducing Lung Volumes in Persons With Chronic Obstructive Pulmonary DiseaseWithdrawnNCT02030145Not applicable
- SILO2 (Signal Intensity Lung washOut)CompletedNCT02024737
- Drug Interaction Study of Azithromycin and TheophyllineCompletedNCT02023554Not applicable
- Biologic Basis Of Increased Susceptibility Of Smokers To Pulmonary Infection With Mycobacterium TuberculosisWithdrawnNCT02021747